Topical steroids:
Indications for: HALOG
Corticosteroid-responsive dermatoses.
Adults and Children:
Apply to affected areas 2–3 times daily. Discontinue when control is achieved. Do not occlude.
HALOG Warnings/Precautions:
Not for oral, ophthalmic, or intravaginal use. Avoid use on face, axilla, or groin. Do not use on pre-existing skin atrophy. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, use of occlusive dressings, altered skin barrier, liver failure, young age; discontinue gradually, reduce dose, or substitute with less potent corticosteroid if occurs. Treat infection if present; discontinue if infection persists or worsens. Avoid abrupt cessation in chronic use. Reevaluate periodically. Pregnancy (Cat.C). Nursing mothers.
See Also:
HALOG Classification:
Corticosteroid.
Adverse Reactions:
Burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, skin maceration, secondary infection, skin atrophy, striae, miliaria; HPA axis suppression (esp. in children); rare: Cushing's syndrome, hyperglycemia, glucosuria.
How Supplied:
Crm, oint—30g, 60g, 240g
